-
Molecular subsets in renal cancer determine outcome to checkpoint and angiogenesis blockade
Study
EGAS00001004353
-
High-grade serous ovarian cancer refined with single-cell RNA-sequencing
Study
EGAS00001004987
-
Intratumoral plasma cells predict outcomes to PD-L1 blockade in non-small cell lung cancer
Study
EGAS00001005013
-
Cryopreservation of human cancers conserves tumour heterogeneity for single-cell multi-omics analysis
Study
EGAS00001005115
-
The PEMDAC phase 2 study of pembrolizumab and entinostat in patients with metastatic uveal melanoma
Study
EGAS00001005478
-
The Proteogenomic Subtypes of Acute Myeloid Leukemia
Study
EGAS00001005950
-
Genome Landscape of High-Grade Serous Ovarian Cancer
Study
EGAS00001000397
-
Stabilising selection causes grossly altered but stable karyotypes in metastatic colorectal cancer
Study
EGAS00001004219
-
Homologous recombination DNA repair deficiency and activity of PARP inhibition in primary triple negative breast cancer
Study
EGAS00001004190
-
Analysis of error profiles in deep next-generation sequencing data
Study
EGAS00001003444
-
TGF-β attenuates tumour response to PD-L1 blockade by contributing to exclusion of T cells.
Study
EGAS00001002556
-
Molecular determinants of response to PD-L1 blockade across tumor types
Study
EGAS00001004343
-
National Human Genome Research Institute Tumor Sequencing Project (TSP) - Lung Adenocarcinoma
Study
phs000144
-
Study of Addiction: Genetics and Environment (SAGE)
Study
phs000092
-
A Genome Wide Scan of Lung Cancer and Smoking
Study
phs000093
-
Whole Genome Association Study of Systemic Lupus Erythematosus
Study
phs000122
-
Neuroblastoma Genome-Wide Association Study (NBL-GWAS)
Study
phs000124
-
Cancer Genetic Markers of Susceptibility (CGEMS) Breast Cancer Genome-wide Association Study (GWAS) - Primary Scan: Nurses' Health Study - Additional Cases: Nurses' Health Study 2
Study
phs000147
-
National Institutes of Health The Cancer Genome Atlas (TCGA)
Study
phs000178
-
High Density SNP Association Analysis of Melanoma: Case-Control and Outcomes Investigation
Study
phs000187
-
Women's Health Initiative Clinical Trial and Observational Study
Study
phs000200
-
International Standards for Cytogenomic Arrays
Study
phs000205
-
Whole Genome Scan for Pancreatic Cancer Risk in the Pancreatic Cancer Cohort Consortium and Pancreatic Cancer Case-Control Consortium (PanScan)
Study
phs000206
-
Cancer Genetic Markers of Susceptibility (CGEMS) Prostate Cancer Genome-Wide Association Study (GWAS) - Primary Scan (Stage 1) - PLCO Screening Trial
Study
phs000207
-
A Genome-Wide Association Study in Patients Experiencing Musculoskeletal Adverse Events on NCIC CTG Trial MA.27 Evaluating Aromatase Inhibitors as Adjuvant Therapy in Early Breast Cancer. A Collaboration Between the NIH Pharmacogenetics Research Network and the RIKEN Yokohama Institute Center for Genomic Medicine.
Study
phs000210